Merozyne Therapeutics launches project to develop a treatment for patients with MDC1A
27 May 2015 | By Victoria White
Merozyne has started a project to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A)...